Mosaic Family Wealth’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$294K Hold
3,269
0.08% 138
2021
Q3
$302K Sell
3,269
-1,050
-24% -$80.9K 0.08% 130
2021
Q2
$336K Hold
4,319
0.1% 122
2021
Q1
$322K Buy
4,319
+219
+5% +$20.2K 0.09% 117
2020
Q4
$699K Buy
4,100
+900
+28% +$133K 0.23% 62
2020
Q3
$449K Sell
3,200
-150
-4% -$22.8K 0.17% 81
2020
Q2
$537K Buy
3,350
+600
+22% +$81.6K 0.22% 63
2020
Q1
$269K Hold
2,750
0.14% 101
2019
Q4
$355K Hold
2,750
0.14% 100
2019
Q3
$207K Buy
2,750
+439
+19% +$51.8K 0.09% 158
2019
Q2
$351K Buy
2,311
+11
+0.5% +$1.34K 0.15% 104
2019
Q1
$274K Buy
2,300
+400
+21% +$51.4K 0.11% 125
2018
Q4
$207K Hold
1,900
0.09% 148
2018
Q3
$222K Hold
1,900
0.09% 143
2018
Q2
$251K Hold
1,900
0.1% 143
2018
Q1
$141K Hold
1,900
0.05% 194
2017
Q4
$106K Hold
1,900
0.04% 231
2017
Q3
$86K Hold
1,900
0.03% 278
2017
Q2
$64K Hold
1,900
0.03% 296
2017
Q1
$56K Hold
1,900
0.02% 307
2016
Q4
$52K Buy
1,900
+300
+19% +$12K 0.02% 316
2016
Q3
$98K Hold
1,600
0.05% 262
2016
Q2
$31K Hold
1,600
0.02% 389
2016
Q1
$31K Buy
1,600
+1,500
+1,500% +$26.2K 0.01% 380
2015
Q4
$3K Buy
+100
New +$3.24K ﹤0.01% 647

Other funds holding SRPT

Mosaic Family Wealth's SRPT Position: Q4 2021 in Review

Mosaic Family Wealth held its Sarepta Therapeutics (SRPT) position steady in Q4 2021 at 3,269 shares worth $294K. The position accounts for 0.08% of the portfolio, ranked #138.

Mosaic Family Wealth first reported a position in SRPT in Q4 2015 and has held it in 25 quarters since. The position peaked at $699K in Q4 2020. 344 funds tracked by Wall St. Rank hold SRPT as of Q4 2021.

  • Mosaic Family Wealth held 3,269 shares of Sarepta Therapeutics worth $294K as of Q4 2021.
  • Mosaic Family Wealth left its Sarepta Therapeutics share count unchanged in Q4 2021.
  • Sarepta Therapeutics made up 0.08% of Mosaic Family Wealth's portfolio in Q4 2021, its #138 holding.
  • Mosaic Family Wealth first reported a position in Sarepta Therapeutics in Q4 2015 and has held it in 25 quarters since.
  • Mosaic Family Wealth's Sarepta Therapeutics position peaked at $699K in Q4 2020.
  • 344 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2021.

Based on Mosaic Family Wealth's 13F filing for Q4 2021, filed 25 Jan 2022.